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Background. Neurological soft signs (NSS) have been inconsistently reported in obsessive-compulsive disorder
(OCD) but may make an impact on treatment response.
Method. The current study examined the presence of NSS in two independent European samples of OCD patients
(combined 85 patients and 88 matched healthy controls) using a standardized instrument and conducted a meta-
analysis of all published studies identiﬁed in the literature with the aim to provide a more deﬁnitive answer to the
question of whether OCD patients are characterized by increased NSS.
Results. Both empirical studies found elevated NSS scores in patients compared with matched controls. The results
of the meta-analysis, which included 15 studies (combined 498 patients and 520 controls) showed large eﬀect sizes
(Hedges’ g=1.27, 95% conﬁdence interval 0.80–1.75), indicating that OCD patients have signiﬁcantly higher rates of
NSS than matched controls on both sides of the body and in multiple domains (motor coordination, sensory
integration and primitive reﬂexes). The results were robust and remained largely unchanged in our reliability
analyses, which controlled for possible outliers. Meta-regression was employed to examine the role of potential
variables of interest including sociodemographic variables, symptom severity, medication eﬀects and the use of
diﬀerent instruments, but none of these variables was clearly associated with NSS.
Conclusions. As a group, OCD patients are characterized by increased rates of NSS, compared with healthy controls.
However, their origins and potential clinical importance remain to be clariﬁed. Future directions for research are
discussed.
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Introduction
Conventionally deﬁned as non-localizing abnor-
malities without diagnostic speciﬁcity, neurological
soft signs (NSS) involve observable defects in sen-
sory integration, motor coordination and primitive
reﬂexes in patients without neurological disorder
(Dazzan & Murray, 2002). NSS have been described
in several psychiatric disorders such as schizophrenia
(Whitty et al. 2009; Chan et al. 2010b), bipolar
disorder (Negash et al. 2004; Whitty et al. 2006),
substance misuse (Keenan et al. 1997; Drvaux et al.
2010), antisocial personality disorder (Lindberg et al.
2004) and post-traumatic stress disorder (Gurvits
et al. 1997).
In obsessive-compulsive disorder (OCD), a number
of studies have explored NSS but the results have been
relatively inconsistent. Some studies found a higher
prevalence of NSS in OCD patients than in healthy
controls (Conde Lo´pez et al. 1990; Hollander et al.
1990; Bihari et al. 1991; Hymas et al. 1991; Nickoloﬀ
et al. 1991; Mataix-Cols et al. 2003; Guz & Aygun, 2004;
Sevincok et al. 2006; Salama et al. 2008), including
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impaired motor coordination (Hollander et al. 1990;
Hymas et al. 1991; Bolton et al. 1998; Mataix-Cols et al.
2003), involuntary movements (Hollander et al. 1990;
Bihari et al. 1991), sensory integration abnormalities
(Bolton et al. 1998; Mataix-Cols et al. 2003; Sevincok
et al. 2006) and presence of primitive reﬂexes (Bolton
et al. 1998). However, other studies did not ﬁnd any
diﬀerences between OCD patients and controls in
either total NSS scores (Stein et al. 1994; Jaafari et al.
2011), or in speciﬁc NSS subdomains such as motor
coordination (Stein et al. 1994; Guz & Aygun, 2004 ;
Sevincok et al. 2006; Poyurovsky et al. 2007), sensory
integration (Hollander et al. 1990; Stein et al. 1994;
Poyurovsky et al. 2007), involuntary movements (Stein
et al. 1994) or primitive reﬂexes (Mataix-Cols et al.
2003).
Detailed examination of these studies indicates
that they are often characterized by relatively small
sample sizes and various potential sources of hetero-
geneity. For example, in some studies patients were
on medication (Bihari et al. 1991; Hymas et al. 1991;
Nickoloﬀ et al. 1991; Bolton et al. 1998; Mataix-
Cols et al. 2003; Guz & Aygun, 2004 ; Poyurovsky
et al. 2007; Jaafari et al. 2011) whereas other studies
recruited unmedicated patients (Hollander et al.
1990; Stein et al. 1994; Sevincok et al. 2006). Another
source of heterogeneity is the use of diﬀerent stan-
dardized instruments to measure NSS, with some
studies employing clinical examinations rather than
standardized instruments (e.g. Hymas et al. 1991;
Caramelli et al. 1996), thus making comparisons diﬃ-
cult.
Given the relative inconsistency of previous studies
and the multiple sources of heterogeneity, the current
study aimed to provide a more clear answer to the
question of whether OCD patients are characterized
by increased NSS compared with matched controls.
This is clinically relevant in the light of emerging
evidence that the presence of NSS in OCD may dif-
ferentially predict treatment response to selective
serotonin reuptake inhibitors (SSRIs) (Hollander
et al. 2005; Mergl et al. 2005) but not cognitive be-
haviour therapy (Bolton et al. 2000). To this end,
we conducted two empirical studies across two
specialist European centres using the same standar-
dized instrument. We next conducted exhaustive
literature searches and performed a meta-analysis
of all existing NSS studies in OCD. We predicted
higher NSS scores in patients compared with controls
in the empirical studies and robust eﬀect sizes in
the same direction in the meta-analysis. Finally, we
employed meta-regression methods to examine the
potential moderating role of symptom severity, medi-
cation use, age of onset, illness duration and other
variables of interest.
Method
Empirical studies
Two parallel studies were conducted in the UK and
Spain. The UK sample consisted of 74 individuals
(35 with OCD and 39 controls) and the Spanish
sample of 99 individuals (50 with OCD and 49 con-
trols). In both samples, trained raters administered the
Cambridge Neurological Inventory (CNI; Chen et al.
1995). A complete description of the participants,
materials and methods can be found in the online
Supplementary Material.
Meta-analysis
Data sources and study selection
A three-stage strategy was implemented to identify
studies suitable for inclusion in the meta-analysis.
First, we conducted a systematic search of the
databases Medline, PsycINFO, PsychARTICLES,
EMBASE, SCOPUS and Google Scholar using the
search terms ‘neurological soft signs ’, ‘neurological
signs ’, ‘ soft signs’, ‘neurological abnormalit* ’, ‘motor
coordination’, ‘ sensory integration’, ‘complex motor
sequencing’, ‘Luria task’, or ‘ﬁst-edge-palm’ with
‘OCD’ or ‘obsessive compulsive disorder ’. Second,
we asked experts in the ﬁeld to identify missing
and unreported studies. Third, we conducted manual
searches of reference lists of empirical studies and re-
view articles. The inclusion criteria speciﬁed that the
article must have included a control group and that
the results must have been reported with suﬃcient
detail for an eﬀect size to be calculated.
Data extraction and synthesis
For each of the selected studies, two authors indepen-
dently extracted the sample size of each group,
the mean and standard deviation of the NSS scores,
and the scores of the NSS subscales and the right
and left NSS where available. Where possible, we also
extracted information for a number of study charac-
teristics. These variables were identiﬁed as potential
sources of heterogeneity and were collected to be used
as covariates in a meta-regression analysis.
Disagreement between the two authors concerning
the extracted data was resolved via discussion until
a consensus was reached. Any uncertainty regarding
the extraction of data from a particular study was re-
solved via contact with the study authors.
Total NSS scores were not reported by Bolton et al.
(1998) and Poyurovsky et al. (2007), so for these studies
the NSS total score was calculated by summing the
scores of the relevant subscales.
1070 N. Jaafari et al.
Standard deviations of the total NSS scores were
not reported in three papers (Hollander et al. 1990;
Bolton et al. 1998; Poyurovsky et al. 2007) and had to be
indirectly obtained. In one study (Hollander et al.
1990), these could be calculated from the histograms
plotted in the paper. In another study (Bolton et al.
1998), standard deviations could be estimated from
the subscores using a basic property of the variance,
namely:
sA+B=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2A+s
2
B+2sAsBrA,B
q
,
where sA and sA are the standard deviations of
two subscores and rA,B is the correlation between
them – as reported in the original validation study of
the CNI (Chen et al. 1995). Finally, a similar method
was used for the data in Poyurovsky et al. (2007),
though in this case the set of correlations reported
in the original validation study of the Neurological
Evaluation Scale (NES; Buchanan & Heinrichs, 1989)
led to a quadratic equation with two close roots for
patients (1.47 and 2.24) and none for controls. In order
to apply the same estimations for patients and controls
we considered the discriminant of the equation to be
null – i.e. equivalent to using the mean of the two es-
timated standard deviations in patients (1.86) and the
optimal standard deviation in controls (1.54).
Data analysis
Meta-analyses were conducted using Stata, version 11
(StataCorp LP, USA). Hedges’ g was calculated for all
measures ; this method estimates the eﬀect size as the
standardized diﬀerence between group means, cor-
rected for small sample size bias (Hunter & Schmidt,
2000). A random-eﬀects model was implemented,
which estimates an error term for between-study
variance based on the assumption that eﬀect size mag-
nitude varies between studies ; this method is a con-
servative eﬀect size estimate, provides more accurate
estimates for conﬁdence intervals (CIs) and substan-
tially reduces the possibility of type I error (Hunter &
Schmidt, 2000 ; Field, 2005).
Next, a meta-inﬂuence analysis was conducted.
The meta-inﬂuence analysis is a form of sensitivity
analysis that allows examination of the possible inﬂu-
ence of individual studies on the overall meta-analysis
summary estimate. Using this method, an average ef-
fect size is calculated while leaving out one study at
a time from the set of studies available for the meta-
analysis.
In order to examine publication bias, we created a
funnel plot and conducted Egger’s test of publication
bias (Egger et al. 1997) for each measure. If there
is no evidence of publication bias, the individual
studies should be symmetrically distributed within
the funnel of the plot and Egger’s test should be non-
signiﬁcant.
Heterogeneity was investigated using a meta-
regression analysis, which examines potential mod-
erators of the eﬀect size (Higgins & Thompson, 2002).
A lack of moderator eﬀect suggests that the moderator
in question does not aﬀect the average eﬀect size
estimate. We computed the x2 statistic Q and the I2
statistic in order to assess the homogeneity of eﬀect
sizes. Moderator analyses were conducted using
random-eﬀects meta-regression analyses with the
study characteristics as covariates using the METAN and
METAREG commands in Stata, version 11. Because of the
increased risk of type I error when making multiple
comparisons, we used a permutation tests approach
(using 1000 Monte Carlo simulations) to calculate
p values (Higgins & Thompson, 2004).
Results
Empirical studies
Compared with healthy controls, patients with OCD
had elevated scores on most NSS subscales, par-
ticularly in the Spanish sample (Table 1). A detailed
description of the results can be found in the
Supplementary Material.
Meta-analysis
Our search strategy yielded 32 studies for potential
inclusion. Of these, 15 met our inclusion criteria.
Table 2 lists the included/excluded studies and rea-
sons for exclusion.
The combined number of participants in these
studies was 1018 (498 OCD and 520 control par-
ticipants). One of the studies included in the meta-
analysis (Stein et al. 1994) comprised 34 OCD subjects
and 16 healthy controls, of which 16 OCD and eight
control participants had been already reported in
another of the included studies (Hollander et al. 1990).
The analysis of the inﬂuence described in the methods
controlled for this circumstance.
The combined sample characteristics were calcu-
lated taking into account the sample size and variances
of each study. The combined sample consisted of in-
dividuals in their 30s (OCD: mean age=33.5 years,
S.D.=9.7 years, range 28.5–36.9 years ; controls : mean
age=33.6 years, S.D.=10.2 years, range 29.6–
38.2 years ; 14 studies), with a similar gender distri-
bution in both groups (OCD: mean percentage
of females=52%; controls : mean percentage of
females=45%; 14 studies), and similar years of edu-
cation (OCD: mean=12.8 years, S.D.=3.9 years ; con-
trols : mean=13.7 years, S.D.=3.6 years ; seven studies).
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For the OCD participants, the severity of the dis-
order, measured with the Yale–Brown Obsessive
Compulsive Scale (YBOCS), was in the moderate
range (mean=23.7, S.D.=7.5, range 17.9–28.5 ; 10
studies). The duration of the illness ranged from 1 to
21 years (mean=12.1 years, S.D.=10.3 years ; eight
studies). The mean age of onset of the illness was
18.1 years (S.D.=7.5 years ; ﬁve studies).
Study characteristics
Studies varied in terms of sample size (OCD: mean=
33.2, S.D.=13.4, range 8–50 participants ; controls :
mean=34.7, S.D.=16.9, range 12–67 participants).
Most of the studies were conducted in Europe
(66.7%), 26.7% in the USA, and one in North Africa
(6.7%).
Most studies employed structured NSS batteries. Of
the included studies, 26.7% used the CNI (Bolton et al.
1998; Mataix-Cols et al. 2003; current studies), 20%
used the NES (Nickoloﬀ et al. 1991; Senincok et al.
2006; Poyurovsky et al. 2007) and 20% used other
validated batteries [two studies used the Physical and
Neurological Examination for Soft Signs (PANESS) :
Guz & Aygun, 2004; Salama et al. 2008; and one
study used Krebs’s scale : Jaafari et al. 2011]. Of the
included studies, ﬁve studies (35.7%) used a NSS
clinical examination (Conde Lo´pez et al. 1990;
Hollander et al. 1990; Bihari et al. 1991; Hymas et al.
1991; Stein et al. 1994).
Only one of the included studies employed raters
who were blind to the participants’ patient or control
status (Hollander et al. 1990).
Publication bias
Examination of the funnel plot (Fig. 1) showed that
the majority of studies were grouped symmetrically
around the mean eﬀect size (with the exception of the
outlier on the right-hand side of the plot ; Bihari et al.
1991), suggesting no evidence of publication bias.
Egger’s test was signiﬁcant (7.2, S.E.=2.8, p<0.05) but
removal of the outlier study (Bihari et al. 1991) from
the analysis resulted in a non-signiﬁcant Egger’s test
(3.3, S.E.=2.5 ; p>0.05) in line with the original ap-
praisal of the funnel plot.
Eﬀect sizes
The eﬀect size calculated for the total NSS was large at
1.27 [Q=158.5, degrees of freedom (df)=14, p<0.001;
15 studies] (Fig. 2). A total of ﬁve studies reported data
for total left and total right NSS. The eﬀect sizes cal-
culated for both left and right NSS were large at 0.72
(Q=21.2, df=4, p<0.001) and 0.68 (Q=24.3, df=4,
p<0.001), respectively. Where available, scores for
the NSS subscales were also obtained. Eﬀect sizes for
the diﬀerent subscales were large with an eﬀect size
of 0.81 (Q=6.9, df=3, p<0.075, n=4) for primitive
reﬂexes, 0.67 (Q=33.2, df=7, p<0.000, n=8) for
sensory integration and 0.61 (Q=104.3, df=8,
Table 1. Mann–Whitney U tests scores showing group diﬀerences in NSS between OCD
and control groups in the UK and Spanish samples
Mean rank
NSS variable OCD Controls U z p
UK sample
Subjects, n 35 39
Primitive reﬂexes 41.70 33.73 535.00 x2.41 0.02
Motor coordination 41.30 34.09 549.50 x1.45 0.15
Sensory integration 39.59 35.63 609.50 x0.80 0.42
Total right NSS 42.04 33.42 523.50 x1.74 0.08
Total left NSS 42.86 32.69 495.00 x2.06 0.04
Total NSS 42.50 33.01 507.50 x1.90 0.06
Spanish sample
Subjects, n 50 49
Primitive reﬂexes 61.27 38.50 661.50 x4.99 0.000
Motor coordination 68.05 31.58 322.50 x6.33 0.000
Sensory integration 57.39 42.46 855.50 x2.71 0.007
Total right NSS 68.07 31.56 321.50 x6.35 0.000
Total left NSS 66.85 32.81 382.50 x5.93 0.000
Total NSS 68.38 31.24 306.00 x6.44 0.000
NSS, Neurological soft signs ; OCD, obsessive-compulsive disorder.
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p<0.000, n=10) for motor coordination (see
Supplementary Material, Figs S1–S5).
The sensitivity analysis that excluded each study at
the time (inﬂuence analysis) indicated that none of the
individual studies exerted particular inﬂuence on the
average eﬀect size (Table 3).
Meta-regression analysis
For total NSS scores, variation in eﬀect size that was
attributable to heterogeneity was high (I2=91.2%).
Meta-regression analyses were therefore conducted in
order to investigate possible sources of heterogeneity
and their inﬂuence on NSS total ﬁndings. The poten-
tial moderator variables examined in reference to the
study characteristics were the year of publication,
the instrument used for the assessment of the NSS, and
the continent where the study was done. The putative
patient characteristic moderators also studied were
gender, handedness, years of education, intelligence
quotient (IQ), age of illness onset, duration of the
Table 2. Summary of the included and excluded studies in the meta-analysis
Subjects, n
Study OCD
Healthy
controls NSS assessment
Included/excluded
(reasons for exclusion)
Hollander et al. (1990) 41 20 Clinical examination Included
Conde Lo´pez et al. (1990) 20 20 Clinical examination Included
Bihari et al. (1991) 39 43 Clinical examination Included
Nickoloﬀ et al. (1991) 8 12 NES Included
Hymas et al. (1991) 17a 16 Clinical examination Included
Stein et al. (1994) 34 16 Clinical examination Included
Bolton et al. (1998) 50 67 CNI Included
Mataix-Cols et al. (2003) 30 30 CNI Included
Guz & Aygun (2004) 30 30 PANESS Included
Sevincok et al. (2006) 25 23 NES Included
Poyurovsky et al. (2007) 20 51 NES Included
Salama et al. (2008) 50 50 PANESS Included
Jaafari et al. (2011) 49 54 Krebs’s scale Included
Current study 1 (UK) 35 39 CNI Included
Current study 2 (Spain) 50 49 CNI Included
Bolton et al. (2000) 35 N.A. CNI Excluded (no control group)
Behar et al. (1984) 7 N.A. Clinical examination Excluded (no control group and missing
key information)
Caramelli et al. (1996) 15 15 Clinical examination Excluded (missing key information)
Denckla (1989) 54 N.A. PANESS Excluded (no control group and missing
key information)
Hollander et al. (1991) 12 12 Clinical examination Excluded (mixed group and missing
key information)
Hollander et al. (2005) 117 N.A. Clinical examination Excluded (no control group)
Sawle et al. (1991) 6 N.A. Clinical examination Excluded (NSS data reported elsewhere)
Schilder (1938) 7 N.A. Clinical examination Excluded (no control group & missing
key information)
Singla et al. (2009) 30 N.A. NES Excluded (no control group and missing
key information)
Stein et al. (1993) 16 8 Clinical examination Excluded (NSS data reported elsewhere)
Stein et al. (1997) 13 12 Clinical examination Excluded (missing key information)
Thienemann et al. (1995) 21 N.A. Clinical examination Excluded (no control group)
Thomsen & Jensen (1991) 61 117 Clinical examination Excluded (missing key information)
Towey et al. (1993) 17 16 Clinical examination Excluded (missing key information)
Towey et al. (1994) 18 15 Clinical examination Excluded (missing key information)
Tumkaya et al. (2012) 30 N.A. NES Excluded (no healthy control group)
OCD, Obsessive-compulsive disorder ; NSS, neurological soft signs ; NES, Neurological Evaluation Scale ; CNI, Cambridge
Neurological Inventory ; PANESS, Physical and Neurological Examination for Soft Signs ; N.A., not applicable.
a All patients in this study were speciﬁcally selected and displayed obsessional slowness.
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illness, medication use, OCD severity and presence of
depressive symptoms.
Of the potential moderator variables examined, none
reached statistical signiﬁcance, including YBOCS score
(SupplementaryMaterial, Fig. S6). However, there was
a trend towards signiﬁcance for year of publication
(b=–0.60, p=0.15), such that the more recently a study
was published the smaller its eﬀect size but this was
probably due to the eﬀect of an outlier (Bihari et al.
1991) (Supplementary Material, Fig. S7). A trend-level
relationship was also found for the NSS instrument
used (b=–0.42, p=0.13), such that studies that used
a clinical examination yielded larger eﬀect sizes fol-
lowed by studies that used the NES battery, the CNI,
and ﬁnally the PANESS (Supplementary Material,
Fig. S8). However, this may be explained by the un-
usually large eﬀect sizes reported by Bihari et al. (1991).
Discussion
This study examined the presence of NSS in two large
European samples of OCD patients and conducted a
Study
Hollander et al. (1990)
Conde López et al. (1990)
Bihari et al. (1991)
Hymas et al. (1991)
Nickoloff et al. (1991)
Stein et al. (1994)
Bolton et al. (1998)
Mataix-Cols et al. (2003)
Guz & Aygun (2004)
Sevincock et al. (2006)
Poyurovsky et al (2007)
Salama et al. (2008)
Jaafari et al. (2011)
Current study 1 (UK)
Current study 2 (Spain)
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Fig. 2. Forest plot for total neurological soft signs score in obsessive-compulsive disorder patients versus healthy controls.
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Fig. 1. Funnel plot for the meta-analysis of total neurological soft signs score in obsessive-compulsive disorder
patients versus healthy controls.
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meta-analysis of all published studies identiﬁed in the
literature with the aim to provide a more deﬁnitive
answer to the question of whether OCD patients
are characterized by increased NSS compared with
matched controls. Both empirical studies found elev-
ated NSS scores in patients compared with matched
controls, although the Spanish sample yielded more
clearly signiﬁcant results. The results of the meta-
analysis revealed large eﬀect sizes in the expected di-
rection. The results were robust and remained largely
unchanged in our reliability analyses, which con-
trolled for possible outliers.
The results conﬁrm the initial ﬁndings of Hollander
et al. (1990) and Conde Lo´pez et al. (1990) and clarify
some of the previous inconsistencies in the literature,
such as the speciﬁc types of NSS that are implicated in
OCD; our results conﬁrm that patients have higher
rates of NSS in the domains of motor coordination,
sensory integration and primitive reﬂexes. The results
further indicate that both sides of the body are im-
plicated in OCD, although only ﬁve studies provided
laterality information. Some previous studies had
suggested a slight predominance of left-sided NSS
in OCD (e.g. Hollander et al. 1990; Mataix-Cols et al.
2003) but both the empirical studies and the meta-
analysis showed robust bilateral diﬀerences between
patients and controls.
The results echo other complementary lines of re-
search, such as kinematic analyses of handwriting
and facial movements (Mavrogiorgou et al. 2001;
Mergl et al. 2003) and performance on oculo-motor
tasks (Jaafari et al. 2011). Together, these ﬁndings help
reconcile previous inconsistencies in the literature,
which may have been caused by small heterogeneous
samples, and suggest subtle central nervous system
alterations in OCD which are broadly consistent with
current neurobiological models of the disorder (e.g.
Saxena & Rauch, 2000). However, alternative explan-
ations are also possible (see below).
Of the two empirical studies, the Spanish sample
yielded larger eﬀect sizes and tighter CIs. These dis-
crepancies may be due to diﬀerences in the patient or
control characteristics, the smaller sample size or in-
creased variability in the UK sample, or a combination
of these factors. Also, the scoring of the CNI was
slightly diﬀerent in the two studies, with the Spanish
study adding an additional ‘subthreshold’ option.
However, the inﬂuence analyses clearly indicated that
the overall results of the meta-analysis were largely
unaﬀected by the contribution of any of the individual
studies.
Whereas the Spanish study found a signiﬁcant
association between NSS scores and OCD severity
(YBOCS scores), the UK study did not (see Supple-
mentary Material). The previous literature is also
mixed in this regard. While some studies found sig-
niﬁcant associations between NSS and YBOCS scores
(e.g. Hollander et al. 1990; Bolton et al. 2000; Salama
et al. 2008), others did not (e.g. Stein et al. 1994, 1997 ;
Sevincok et al. 2006; Jaafari et al. 2011; Karadag et al.
2011). Similarly, our meta-regression analysis also
failed to conﬁrm a signiﬁcant association with symp-
tom severity. This negative ﬁnding may be due to the
relatively small variability in YBOCS scores across
studies. Alternatively, NSS may be unrelated to ﬂuc-
tuations in OCD symptom severity and, rather, rep-
resent a trait marker of the disorder. As reviewed in
the introduction, NSS are observed in multiple mental
disorders, not just OCD. Thus, NSS may be non-
speciﬁc markers of psychopathology in general. This
raises the question of whether NSS may also be pres-
ent in ﬁrst-degree relatives of OCD patients and thus
represent useful endophenotypes for OCD research,
as has been suggested in schizophrenia (Chan et al.
2010a). Examination of NSS in unaﬀected ﬁrst-degree
relatives of OCD patients would be a worthwhile
avenue for future research.
Interestingly, in both empirical studies, NSS
scores signiﬁcantly correlated with the severity of de-
pressive symptoms (see Supplementary Material).
Unfortunately, we did not have suﬃcient data to con-
duct a meta-regression analysis to conﬁrm these ﬁnd-
ings. If conﬁrmed, one parsimonious interpretation
may be that low mood interferes with appropriate
performance on the NSS tasks, rather than represent
a marker of central nervous system dysfunction.
Table 3. Results of the inﬂuence analysis in which the eﬀect sizes
are re-estimated omitting one study at the time
Study omitted
Eﬀect size
estimate (95% CI)
Hollander et al. (1990) 1.30 (0.79–1.81)
Conde Lo´pez et al. (1990) 1.30 (0.80–1.81)
Bihari et al. (1991) 0.98 (0.65–1.31)
Hymas et al. (1991) 1.27 (0.77–1.78)
Nickoloﬀ et al. (1991) 1.23 (0.74–1.72)
Stein et al. (1994) 1.34 (0.84–1.84)
Bolton et al. (1998) 1.26 (0.75–1.77)
Mataix-Cols et al. (2003) 1.29 (0.78–1.81)
Guz & Aygun (2004) 1.33 (0.82–1.84)
Sevincok et al. (2006) 1.32 (0.81–1.82)
Poyurovsky et al. (2007) 1.24 (0.74–1.74)
Salama et al. (2008) 1.32 (0.79–1.84)
Jaafari et al. (2011) 1.37 (0.91–1.84)
Current study 1 (UK) 1.34 (0.83–1.85)
Current study 2 (Spain) 1.25 (0.75–1.76)
Combined 1.27 (0.80–1.75)
CI, Conﬁdence interval.
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Alternatively, NSS may be associated with an in-
creased risk and severity of psychiatric symptoms in
general, including depression, although the current
design does not allow us to examine the direction
of such ﬁndings. In any case, comparison of OCD
patients with and without co-morbid depression is
needed in order to further clarify this issue (in the
current study, only seven patients in each of the
empirical samples met diagnostic criteria for major
depression and thus meaningful comparisons were
not possible).
Years of education were signiﬁcantly (negatively)
correlated with NSS in both empirical studies (see
Supplementary Material) but this variable could not
be examined in the meta-regression due to the lack of
suﬃcient data. The design of the current study does
not permit causal interpretations but it is possible that
individuals with subtle neurological deﬁcits represent
a particularly impaired subgroup of OCD patients,
characterized by learning diﬃculties and cognitive
impairment. For example, Hertzig (1981) found that
children with soft signs were signiﬁcantly more likely
to have received special education and to have
been referred for psychiatric consultation than were
neurologically normal children. This is also consistent
with a body of evidence that links increased NSS
with poorer neuropsychological performance in OCD
(Hollander et al. 1990; Bolton et al. 2000; Mataix-Cols
et al. 2003) and other psychiatric disorders (e.g.
Flashman et al. 1996; Arango et al. 1999). Nevertheless,
the alternative interpretation (i.e. that poorer edu-
cational attainment is responsible for the impaired
NSS performance in OCD) cannot be fully ruled out at
this stage.
None of the other potentially moderating variables
we examined (i.e. gender, handedness, IQ, age of ill-
ness onset, duration of the illness, or medication
use) was signiﬁcantly associated with NSS in OCD.
Regarding the lack of medication eﬀects, the results
are consistent with several studies that found no in-
ﬂuence of medication on NSS in OCD (Bihari et al.
1991; Hymas et al. 1991; Thienemann & Koran, 1995 ;
Caramelli et al. 1996; Bolton et al. 1998; Guz & Aygun,
2004 ; Poyurovsky et al. 2007; Salama et al. 2008; Jaafari
et al. 2011; Karadag et al. 2011), or in other disorders
such as schizophrenia (Heinrichs & Buchanan, 1988 ;
Chan et al. 2010b) or bipolar disorder (Cherian &
Kuruvilla, 1989 ; Noroozian et al. 2009). Perhaps anti-
psychotics may have more clearly moderating eﬀects
on NSS, but only four studies included in this meta-
analysis contained a small proportion of patients
who were prescribed low doses of antipsychotics as an
augmentation strategy (Hymas et al. 1991; Poyurovsky
et al. 2007; Jaafari et al. 2011; current study – Spanish
sample). In any case, a recent meta-analysis of NSS
studies in schizophrenia concluded: ‘ the majority of
studies demonstrated no signiﬁcant results suggesting
that [antipsychotic] treatment might not be a signiﬁ-
cant moderator ’ (Chan et al. 2010b ; p. 1097). Thus,
based on the available evidence, it appears unlikely
that medication played a substantial role in the current
results.
Directions for future research
As seen above, several important questions remain but
the current ﬁndings point towards speciﬁc areas that
require further research.
First, it is currently unclear whether NSS precede
the development of OCD or are a consequence of the
disorder. Prospective longitudinal studies are needed
to fully address this question, although there are some
indications in the literature that NSS may precede and
represent a risk factor for OCD as well as other mental
disorders. In a rare prospective study, Grisham et al.
(2011) examined childhood risk factors for an adult
OCD diagnosis in a New Zealand birth cohort.
They reported that poor motor skills in childhood
(ages 3–9 years) speciﬁcally predicted the presence of
OCD symptoms involving fears of harm and checking
rituals. These results are consistent with a previous
study by the same group, which demonstrated that
deﬁcits in visuospatial, visuoconstructive and visuo-
motor skills in childhood were speciﬁcally associated
with an adult diagnosis of OCD (Grisham et al. 2009).
Other researchers have also reported that NSS in
childhood are predictive of a variety of psychiatric
disorders later in life (Shaﬀer et al. 1983; Hollander
et al. 1991; Fish et al. 1992; Pine et al. 1993; Jones et al.
1994). Therefore, NSS may represent neurodevelop-
mental risk factors for a variety of psychiatric con-
ditions, including OCD. However, it cannot be entirely
ruled out that at least some of the reported ﬁndings are
secondary to OCD symptoms, as there is some evi-
dence that NSS and other motor abnormalities can
improve with successful treatment. For example, a
study by Mergl et al. (2004) found that drawing speed
was impaired in OCD compared with healthy controls
but normalized after 10-week treatment with sertraline
and behaviour therapy. Another potentially useful
way to address the state versus trait question in OCD
may be the comparison of symptomatic versus fully
remitted patients or, as mentioned earlier, the study of
unaﬀected ﬁrst-degree relatives of OCD patients.
Another area of interest is whether the NSS have
any prognostic value in OCD and therefore have a
potential use in clinical settings. It has been suggested
that NSS may be useful predictors of treatment re-
sponse to SSRIs in OCD. For example, Hollander et al.
(2005) found that left-sided visuospatial soft signs
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were signiﬁcantly increased in non-responders com-
pared with responders to SSRIs. Meanwhile, Mergl
et al. (2005) found that non-responders to a combi-
nation of sertraline and behaviour therapy exhibited
more motor soft signs at baseline, compared with
treatment responders. However, Thienemann &
Koran (1995) failed to ﬁnd a link between NSS and
response to SSRIs. Moreover, from the limited evi-
dence, it does not seem that NSS are predictive of
clinical response to behaviour therapy for OCD
(Bolton et al. 2000). Taken together, the ﬁndings of this
limited body of research raise the intriguing possi-
bility that NSS assessment may be useful to guide
treatment strategies in OCD but clearly more research
is needed to establish their potential clinical use.
Limitations
One of the main limitations of the two empirical stu-
dies and the vast majority of studies included in the
meta-analysis (except Hollander et al. 1990) was that
examiners, though trained in most cases, were not
blind to diagnosis, thus potentially resulting in the
over-rating of NSS in the patients. This was partially
overcome in the UK study, where 40% of the partici-
pants were double scored by a second examiner and
the inter-rater reliability was found to be generally
excellent (see Supplementary Material). It is also note-
worthy that the eﬀect size obtained in the meta-
analysis is very similar to that obtained in the original
Hollander et al. (1990) study, which did employ a
blind methodology. Another important limitation is
the cross-sectional nature of the research, which pre-
cludes ﬁrm conclusions regarding the nature and ori-
gin of NSS in OCD; prospective longitudinal studies
are needed. Diﬀerent studies employed diﬀerent in-
struments to assess NSS but our meta-regression and
subgroup analyses showed that the results were robust
and independent of the instruments used. A similar
meta-analysis in schizophrenia also found that the use
of diﬀerent instruments had no noticeable eﬀect on the
results (Chan et al. 2010b). Several important variables
such as co-morbidity with tic disorders or depression,
speciﬁc OCD symptom dimensions, obsessional slow-
ness, or degree of insight were not systematically
included in the original studies and therefore could
not be investigated in the meta-analysis. It may be that
NSS are particularly prominent in certain groups of
patients and thus examination of these variables re-
mains an objective for future research.
Conclusions
As a group, patients with OCD have elevated rates of
subtle neurological signs, which rather than being
speciﬁc to OCD, may represent markers of psycho-
pathology in general. However, the origins and po-
tential clinical importance of NSS in OCD remain to be
clariﬁed.
Supplementary material
For supplementary material accompanying this paper
visit http://dx.doi.org/10.1017/S0033291712002012.
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